Literature DB >> 23749407

Review on intermediate filaments of the nervous system and their pathological alterations.

Claire Lépinoux-Chambaud1, Joël Eyer.   

Abstract

Intermediate filaments (IFs) of the nervous system, including neurofilaments, α-internexin, glial fibrillary acidic protein, synemin, nestin, peripherin and vimentin, are finely expressed following elaborated cell, tissue and developmental specific patterns. A common characteristic of several neurodegenerative diseases is the abnormal accumulation of neuronal IFs in cell bodies or along the axon, often associated with impairment of the axonal transport and degeneration of neurons. In this review, we also present several perturbations of IF metabolism and organization associated with neurodegenerative disorders. Such modifications could represent strong markers of neuronal damages. Moreover, recent data suggest that IFs represent potential biomarkers to determine the disease progression or the differential stages of a neuronal disorder. Finally, recent investigations on IF expression and function in cancer provide evidence that they may be useful as markers, or targets of brain tumours, especially high-grade glioma. A better knowledge of the molecular mechanisms of IF alterations, combined to neuroimaging, is essential to improve diagnosis and therapeutic strategies of such neurodegenerative diseases and glioma.

Entities:  

Mesh:

Year:  2013        PMID: 23749407     DOI: 10.1007/s00418-013-1101-1

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  97 in total

1.  Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin.

Authors:  J V Shah; L A Flanagan; P A Janmey; J F Leterrier
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease.

Authors:  R Constantinescu; B Holmberg; L Rosengren; O Corneliusson; B Johnels; H Zetterberg
Journal:  Acta Neurol Scand       Date:  2010-10-29       Impact factor: 3.209

Review 3.  Intermediate filament proteins and their associated diseases.

Authors:  M Bishr Omary; Pierre A Coulombe; W H Irwin McLean
Journal:  N Engl J Med       Date:  2004-11-11       Impact factor: 91.245

4.  Axonal damage markers in cerebrospinal fluid are increased in ALS.

Authors:  J Brettschneider; A Petzold; S D Süssmuth; A C Ludolph; H Tumani
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

5.  Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.

Authors:  E Noetzel; M Rose; E Sevinc; R-D Hilgers; A Hartmann; A Naami; R Knüchel; E Dahl
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

6.  Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability.

Authors:  Y K Semra; O A Seidi; M K Sharief
Journal:  J Neuroimmunol       Date:  2002-01       Impact factor: 3.478

7.  1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis.

Authors:  Karine S Durand; Angélique Guillaudeau; Nicolas Weinbreck; Rafaël DeArmas; Sandrine Robert; Alain Chaunavel; Isabelle Pommepuy; Sylvie Bourthoumieu; François Caire; Franck G Sturtz; François J Labrousse
Journal:  Mod Pathol       Date:  2010-01-15       Impact factor: 7.842

Review 8.  Neuronal intermediate filaments and neurodegenerative disorders.

Authors:  Rodolphe Perrot; Joël Eyer
Journal:  Brain Res Bull       Date:  2009-06-17       Impact factor: 4.077

9.  Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

Authors:  Sara Hall; Annika Öhrfelt; Radu Constantinescu; Ulf Andreasson; Yulia Surova; Frederick Bostrom; Christer Nilsson; Widner Håkan; Hilde Decraemer; Katarina Någga; Lennart Minthon; Elisabet Londos; Eugeen Vanmechelen; Björn Holmberg; Henrik Zetterberg; Kaj Blennow; Oskar Hansson
Journal:  Arch Neurol       Date:  2012-11

10.  Mitosis and intermediate-sized filaments in developing skeletal muscle.

Authors:  H Ishikawa; R Bischoff; H Holtzer
Journal:  J Cell Biol       Date:  1968-09       Impact factor: 10.539

View more
  25 in total

1.  In focus in Prague: intermediate filaments.

Authors:  Jürgen Roth; Paul Debbage; Pavel Hozák
Journal:  Histochem Cell Biol       Date:  2013-06-07       Impact factor: 4.304

2.  Missense variants in AIMP1 gene are implicated in autosomal recessive intellectual disability without neurodegeneration.

Authors:  Zafar Iqbal; Lucia Püttmann; Luciana Musante; Attia Razzaq; Muhammad Yasir Zahoor; Hao Hu; Thomas F Wienker; Masoud Garshasbi; Zohreh Fattahi; Christian Gilissen; Lisenka E L M Vissers; Arjan P M de Brouwer; Joris A Veltman; Rolph Pfundt; Hossein Najmabadi; Hans-Hilger Ropers; Sheikh Riazuddin; Kimia Kahrizi; Hans van Bokhoven
Journal:  Eur J Hum Genet       Date:  2015-07-15       Impact factor: 4.246

3.  Myopathic changes in murine skeletal muscle lacking synemin.

Authors:  Karla P García-Pelagio; Joaquin Muriel; Andrea O'Neill; Patrick F Desmond; Richard M Lovering; Linda Lund; Meredith Bond; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2015-01-07       Impact factor: 4.249

4.  Pathogenic variants in AIMP1 cause pontocerebellar hypoplasia.

Authors:  Andrea Accogli; Laura Russell; Guillaume Sébire; Jean-Baptiste Rivière; Judith St-Onge; Nassima Addour-Boudrahem; Alexandre Dionne Laporte; Guy A Rouleau; Christine Saint-Martin; Myriam Srour
Journal:  Neurogenetics       Date:  2019-03-28       Impact factor: 2.660

Review 5.  The Histochem Cell Biol conspectus: the year 2013 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2014-03-09       Impact factor: 4.304

Review 6.  TDP-43 and Cytoskeletal Proteins in ALS.

Authors:  Moritz Oberstadt; Joseph Claßen; Thomas Arendt; Max Holzer
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

7.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

Review 8.  Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin.

Authors:  Elly M Hol; Yassemi Capetanaki
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

Review 9.  Dynamic self-guiding analysis of Alzheimer's disease.

Authors:  Alexei Kurakin; Dale E Bredesen
Journal:  Oncotarget       Date:  2015-06-10

Review 10.  Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.

Authors:  Manny D Bacolod; Swadesh K Das; Upneet K Sokhi; Steven Bradley; David A Fenstermacher; Maurizio Pellecchia; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2015-05-23       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.